Literature DB >> 30523027

Multimodal Imaging of the Initial Stages of Diabetic Retinopathy: Different Disease Pathways in Different Patients.

Inês P Marques1, Dalila Alves1, Torcato Santos1, Luís Mendes1, Ana Rita Santos1, Conceição Lobo1,2, Mary Durbin3, José Cunha-Vaz4,2.   

Abstract

The objective of this study was to evaluate the prevalence of different disease pathways (ischemia, neurodegeneration, and edema) in the initial stages of diabetic retinopathy. In this retrospective cross-sectional study, eyes were grouped by diabetic retinopathy severity using the 7-field Early Treatment Diabetic Retinopathy Study (ETDRS) protocol (levels 10-20, 35, and 43-47). Neurodegeneration was identified by thinning of the retinal nerve fiber layer and/or ganglion cell layer. Edema was identified by thickening of the inner nuclear layer, outer plexiform layer, or full retina. Ischemia was identified by metrics of retinal vessel density. Imaging was performed in 142 eyes from 142 patients (28% women) aged 52-88 years. Vessel density (ischemia) was significantly different between the ETDRS groups (P < 0.020). On multivariate regression analysis, it remained significantly different between stages of the disease and showed associations with age (P < 0.001), sex (P = 0.028), and metabolic control (P = 0.034). No significant differences between ETDRS groups were found in retinal thinning (neurodegeneration) or retinal thickness (edema). Eyes with the same ETDRS retinopathy grading from different patients with diabetes showed that the prevalence of different disease pathways varies between patients, even within the same severity group. Ischemia (capillary dropout) is the only disease pathway that shows correlation with retinopathy severity and metabolic control.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2018        PMID: 30523027     DOI: 10.2337/db18-1077

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  [Unmet research and developmental needs in ophthalmology : A consensus-based road map of the European Vision Institute for 2019-2025].

Authors:  C Cursiefen; F Cordeiro; J Cunha-Vaz; T Wheeler-Schilling; H P N Scholl
Journal:  Ophthalmologe       Date:  2019-09       Impact factor: 1.059

2.  Correlation between Choroidal Vascularity Index and Outer Retina in Patients with Diabetic Retinopathy.

Authors:  Patryk Sidorczuk; Iwona Obuchowska; Joanna Konopinska; Diana A Dmuchowska
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

3.  A Central Role for Ischemia and OCTA Metrics to Follow DR Progression.

Authors:  José Cunha-Vaz
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

Review 4.  Optical Coherence Tomography (Angiography) Biomarkers in the Assessment and Monitoring of Diabetic Macular Edema.

Authors:  Corina-Iuliana Suciu; Vlad-Ioan Suciu; Simona-Delia Nicoara
Journal:  J Diabetes Res       Date:  2020-12-31       Impact factor: 4.011

Review 5.  Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease.

Authors:  William B Horton; Eugene J Barrett
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

6.  Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study.

Authors:  Ana Rita Santos; Luis Mendes; Maria Helena Madeira; Ines P Marques; Diana Tavares; João Figueira; Conceição Lobo; José Cunha-Vaz
Journal:  J Clin Med       Date:  2021-05-15       Impact factor: 4.241

7.  Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study.

Authors:  Inês P Marques; Sophie Kubach; Torcato Santos; Luís Mendes; Maria H Madeira; Luis de Sisternes; Diana Tavares; Ana Rita Santos; Warren Lewis; Conceição Lobo; Mary K Durbin; José Cunha-Vaz
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

8.  En face slab optical coherence tomography imaging successfully monitors progressive degenerative changes in the innermost layer of the diabetic retina.

Authors:  Atsuko Katsuyama; Sentaro Kusuhara; Shun-Ichiro Asahara; Shun-Ichiro Nakai; Sotaro Mori; Wataru Matsumiya; Akiko Miki; Takuji Kurimoto; Hisanori Imai; Yoshiaki Kido; Wataru Ogawa; Makoto Nakamura
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03

9.  Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone.

Authors:  Zita Wachal; Mariann Bombicz; Dániel Priksz; Csaba Hegedűs; Diána Kovács; Adrienn Mónika Szabó; Rita Kiss; József Németh; Béla Juhász; Zoltán Szilvássy; Balázs Varga
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 5.923

10.  Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression.

Authors:  Inês P Marques; Maria H Madeira; Ana L Messias; António C-V Martinho; Torcato Santos; David C Sousa; João Figueira; José Cunha-Vaz
Journal:  Acta Diabetol       Date:  2020-10-06       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.